Literature DB >> 6178848

ML antigen of DBA/2 mouse leukemias: expression of an endogenous murine mammary tumor virus.

J Racevskis, N H Sarkar.   

Abstract

Spontaneous, transplantable leukemias of DBA/2 mice express an antigen (ML) which cross-reacts with antigens of murine mammary tumor virus (MuMTV). The MuMTV cross-reactive antigen of the DBA/2 leukemias (ML cells) was found to be a glycoprotein of 78,000 molecular weight containing antigenic determinants of the major MuMTV glycoprotein gp52. No MuMTV particles were produced by the ML cells, although they did contain type A particles--the pronucleocapsids of MuMTV. The ML antigen appeared to be an aberrant form of the intracellular MuMTV env precursor molecular prgp70, which was not processed properly but instead acquired extra carbohydrate groups and was expressed in uncleaved form on the cell surface. Isolation of MuMTV core protein p28 from the leukemic cells and subsequent tryptic peptide mapping analysis showed that the p28 from leukemia cells differed from the p28 of MuMTV isolated from DBA/2 mouse milk. These observations indicate that the MuMTV expressed in DBA/2 leukemic spleen cells is of a different strain than the virus secreted in lactating mammary glands of DBA/2 mice and probably represents the expression of an endogenous DBA/2 provirus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178848      PMCID: PMC256914          DOI: 10.1128/JVI.42.3.804-813.1982

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Quantitation of virus-induced (MLr) and normal (Thy.1.2) cell surface antigens in isolated plasma membranes and the extracellular ascites fluid of mouse leukemia cells.

Authors:  W J Van Blitterswijk; P Emmelot; J Hilgers; D Kamlag; R Nusse; C A Feltkamp
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

2.  Oncornavirus budding: kinetics of formation and utilization of viral membrane glycoprotein.

Authors:  O N Witte; I L Weissman
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

3.  External labeling of human erythrocyte glycoproteins. Studies with galactose oxidase and fluorography.

Authors:  C G Gahmberg
Journal:  J Biol Chem       Date:  1976-01-25       Impact factor: 5.157

4.  Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.

Authors:  J Hilgers; J Haverman; R Nusse; W J van Blitterswijk; F J Cleton; P C Hageman; P van Nie; J Calafat
Journal:  J Natl Cancer Inst       Date:  1975-06       Impact factor: 13.506

5.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

6.  Influence of mammary tumor virus infection on the acceptance or rejection of transplanted ML+ leukemias.

Authors:  R C Nowinski; E A Boyse; L J Old; E A Carswell
Journal:  Proc Soc Exp Biol Med       Date:  1968-01

7.  Polypeptides of the mouse mammary tumor virus. I. Characterization of two group-specific antigens.

Authors:  N H Sarkar; A S Dion
Journal:  Virology       Date:  1975-04       Impact factor: 3.616

8.  Immunoaffinity chromatography of proteins.

Authors:  D M Livingston
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

9.  Distribution of virus particles and mammary tumor virus antigens in mouse mammary tumors, transformed BALB-c mouse kidney cells, and GR ascites leukemia cells.

Authors:  J Calafat; F Buijs; P C Hageman; J Links; J Hilgers; A Hekman
Journal:  J Natl Cancer Inst       Date:  1974-10       Impact factor: 13.506

10.  Effect of trypsin on mouse mammary tumor virus.

Authors:  J B Sheffield; C M Zacharchuk; N Taraschi; T M Daly
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

View more
  9 in total

1.  Expression of the protein product of the mouse mammary tumor virus long terminal repeat gene in phorbol ester-treated mouse T-cell-leukemia cells.

Authors:  J Racevskis
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

2.  Altered mouse mammary tumor virus transcript synthesis in T-cell lymphoma cells.

Authors:  J Racevskis
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

3.  Direct detection of exogenous mouse mammary tumor virus sequences in lymphoid cells of BALB/cfC3H female mice.

Authors:  T J Liegler; P B Blair
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

4.  Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat.

Authors:  S Yanagawa; A Murakami; H Tanaka
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

Review 5.  Presence of a mouse mammary tumour virus-like in feline lymphomas: a preliminary study.

Authors:  Francesca Parisi; Francesca Lessi; Michele Menicagli; Prospero Civita; Romano Liotti; Francesca Millanta; Giulia Freer; Mauro Pistello; Chiara Maria Mazzanti; Alessandro Poli
Journal:  Infect Agent Cancer       Date:  2022-06-23       Impact factor: 3.698

6.  Mouse mammary tumor virus with rearranged long terminal repeats causes murine lymphomas.

Authors:  S Yanagawa; K Kakimi; H Tanaka; A Murakami; Y Nakagawa; Y Kubo; Y Yamada; H Hiai; K Kuribayashi; T Masuda
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

7.  Proteins encoded by the long terminal repeat region of mouse mammary tumor virus: identification by hybrid-selected translation.

Authors:  J Racevskis; O Prakash
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

8.  DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivity.

Authors:  O Marelli; P Franco; G Canti; L Ricci; N Prandoni; A Nicolin; H Festenstein
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

9.  Identification and characterization of a mouse mammary tumor virus protein uniquely expressed on the surface of BALB/cV mammary tumor cells.

Authors:  B L Slagle; J S Butel
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.